Alvotech Company Leadership
| ALVO Stock | USD 11.31 0.01 0.09% |
Alvotech employs about 999 people. The company is managed by 17 executives with a total tenure of roughly 2331 years, averaging almost 137.0 years of service per executive, having 58.76 employees per reported executive. Analysis of Alvotech's management performance can provide insight into the firm performance.
Alvotech |
Alvotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.0104) % which means that it has lost $0.0104 on every $100 spent on assets. This is way below average. Alvotech's management efficiency ratios could be used to measure how well Alvotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of March 2025, Return On Tangible Assets is likely to drop to -0.72. In addition to that, Return On Capital Employed is likely to drop to -0.62. At this time, Alvotech's Intangibles To Total Assets are very stable compared to the past year. As of the 18th of March 2025, Fixed Asset Turnover is likely to grow to 0.31, while Total Assets are likely to drop about 784 M.As of the 18th of March 2025, Common Stock Shares Outstanding is likely to drop to about 160.8 M. In addition to that, Net Loss is likely to grow to about (439.1 M)
Alvotech Workforce Comparison
Alvotech is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 53,061. Alvotech claims roughly 999 in number of employees contributing just under 2% to equities under Health Care industry.
Alvotech Profit Margins
The company has Profit Margin (PM) of (1.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.49 | 0.53 |
|
|
Alvotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Alvotech Price Series Summation is a cross summation of Alvotech price series and its benchmark/peer.
Alvotech Notable Stakeholders
An Alvotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Alvotech often face trade-offs trying to please all of them. Alvotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Alvotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Faysal Kalmoua | COO Director | Profile | |
| Benedikt Stefansson | VP Communications | Profile | |
| Christina Siniscalchi | Interim Officer | Profile | |
| Ming Li | Chief Officer | Profile | |
| Sandra Casaca | Chief Officer | Profile | |
| RoseMarie Ohlsson | Chief Officer | Profile | |
| Anil Okay | Chief Officer | Profile | |
| Giedrius Zunda | Chief Officer | Profile | |
| Sean Gaskell | Chief Officer | Profile | |
| Joel Morales | Chief Officer | Profile | |
| Joseph McClellan | Chief Officer | Profile | |
| Eva Gunnlaugsdottir | Vice Culture | Profile | |
| Tanya Zharov | General Counsel | Profile | |
| Mark Levick | Chief Officer | Profile | |
| Sigridur Gudlaugsdottir | VP HR | Profile | |
| Jenny Steingrimsdottir | Vice Culture | Profile | |
| Robert Wessman | Founder Directors | Profile |
About Alvotech Management Performance
The success or failure of an entity such as Alvotech often depends on how effective the management is. Alvotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Alvotech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Alvotech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.69) | (0.72) | |
| Return On Capital Employed | (0.59) | (0.62) | |
| Return On Assets | (0.67) | (0.70) | |
| Return On Equity | 0.53 | 0.49 |
Alvotech Workforce Analysis
Traditionally, organizations such as Alvotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Alvotech within its industry.Alvotech Manpower Efficiency
Return on Alvotech Manpower
| Revenue Per Employee | 91.5K | |
| Revenue Per Executive | 5.4M | |
| Net Loss Per Employee | 552.3K | |
| Net Loss Per Executive | 32.5M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.70) | Earnings Share (1.85) | Revenue Per Share | Quarterly Revenue Growth 4.786 | Return On Assets |
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.